Works matching IS 15747891 AND DT 2024 AND VI 18 AND IP 4
Results: 34
Links between melanoma germline risk loci, driver genes and comorbidities: insight from a tissue‐specific multi‐omic analysis.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 1031, doi. 10.1002/1878-0261.13599
- By:
- Publication type:
- Article
Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma model.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 969, doi. 10.1002/1878-0261.13596
- By:
- Publication type:
- Article
Oncolytic adenoviruses and immunopeptidomics: a convenient marriage.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 781, doi. 10.1002/1878-0261.13648
- By:
- Publication type:
- Article
From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021‐lessons learned and implications.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 785, doi. 10.1002/1878-0261.13632
- By:
- Publication type:
- Article
PIKFYVE inhibitors trigger interleukin‐24‐dependent cell death of autophagy‐dependent melanoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 988, doi. 10.1002/1878-0261.13607
- By:
- Publication type:
- Article
Harmony in chaos: understanding cancer through the lenses of developmental biology.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 793, doi. 10.1002/1878-0261.13594
- By:
- Publication type:
- Article
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 797, doi. 10.1002/1878-0261.13591
- By:
- Publication type:
- Article
New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 832, doi. 10.1002/1878-0261.13587
- By:
- Publication type:
- Article
Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in in vivo models.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 1012, doi. 10.1002/1878-0261.13585
- By:
- Publication type:
- Article
Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 918, doi. 10.1002/1878-0261.13553
- By:
- Publication type:
- Article
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 895, doi. 10.1002/1878-0261.13534
- By:
- Publication type:
- Article
The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 939, doi. 10.1002/1878-0261.13526
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 779, doi. 10.1002/1878-0261.13458
- Publication type:
- Article
PIKFYVE inhibitors trigger interleukin‐24‐dependent cell death of autophagy‐dependent melanoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 988, doi. 10.1002/1878-0261.13607
- By:
- Publication type:
- Article
Links between melanoma germline risk loci, driver genes and comorbidities: insight from a tissue‐specific multi‐omic analysis.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 1031, doi. 10.1002/1878-0261.13599
- By:
- Publication type:
- Article
MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 850, doi. 10.1002/1878-0261.13440
- By:
- Publication type:
- Article
Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293
- By:
- Publication type:
- Article
Oncolytic adenoviruses and immunopeptidomics: a convenient marriage.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 781, doi. 10.1002/1878-0261.13648
- By:
- Publication type:
- Article
From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021‐lessons learned and implications.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 785, doi. 10.1002/1878-0261.13632
- By:
- Publication type:
- Article
YB‐1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 815, doi. 10.1002/1878-0261.13367
- By:
- Publication type:
- Article
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 866, doi. 10.1002/1878-0261.13351
- By:
- Publication type:
- Article
Global pannexin 1 deletion increases tumor‐infiltrating lymphocytes in the BRAF/Pten mouse melanoma model.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 969, doi. 10.1002/1878-0261.13596
- By:
- Publication type:
- Article
Harmony in chaos: understanding cancer through the lenses of developmental biology.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 793, doi. 10.1002/1878-0261.13594
- By:
- Publication type:
- Article
Pleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 797, doi. 10.1002/1878-0261.13591
- By:
- Publication type:
- Article
New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 832, doi. 10.1002/1878-0261.13587
- By:
- Publication type:
- Article
MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 850, doi. 10.1002/1878-0261.13440
- By:
- Publication type:
- Article
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 866, doi. 10.1002/1878-0261.13351
- By:
- Publication type:
- Article
Enhancing therapeutic efficacy in triple‐negative breast cancer and melanoma: synergistic effects of modulated electro‐hyperthermia (mEHT) with NSAIDs especially COX‐2 inhibition in in vivo models.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 1012, doi. 10.1002/1878-0261.13585
- By:
- Publication type:
- Article
The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 939, doi. 10.1002/1878-0261.13526
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 779, doi. 10.1002/1878-0261.13458
- Publication type:
- Article
Ceftriaxone exerts antitumor effects in MYCN‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 918, doi. 10.1002/1878-0261.13553
- By:
- Publication type:
- Article
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 895, doi. 10.1002/1878-0261.13534
- By:
- Publication type:
- Article
Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293
- By:
- Publication type:
- Article
YB‐1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 815, doi. 10.1002/1878-0261.13367
- By:
- Publication type:
- Article